带介导的向药物递送方法对抗肝细胞癌
Amrita Singh1, Sudhanshu Mishra1, Saurabh Sharma2
1Department of Pharmaceutical Science & Technology, Madan Mohan Malaviya University of Technology, Gorakhpur, India.
Current cancer drug targets
|September 1, 2023
概括
癌症是全球主要的健康问题,每年导致数百万人的死亡. 肝细胞癌 (HCC) 治疗因药物输送问题而面临挑战,需要针对性治疗以获得更好的结果.
科学领域:
- 在瘤学瘤学.
- 肝病学 肝病学是一种肝病学.
- 纳米医学是一种纳米医学.
背景情况:
- 癌症仍然是全球主要的健康问题,肝细胞癌 (HCC) 是癌症相关死亡的主要原因.
- 肝癌的发展与肝病和慢性乙型肝炎和型肝炎感染密切相关.
- 传统的癌症疗法由于药物分布不良,多药耐药性和显著的副作用,往往效果不佳.
研究的目的:
- 为了解决肝细胞癌常规疗法的局限性.
- 探索创新的药物输送策略,以改善癌症治疗.
- 突出向药物分子和纳米载体在提高治疗结果方面的潜力.
主要方法:
- 研究了肝癌常规药物治疗的挑战,包括物理障碍和低于最佳的药物度.
- 探索了创新的向技术,包括将向连接物与药物分子或纳米载体相结合.
- 鉴定了针对肝细胞癌细胞的特定向配体,如亚洲糖蛋白,银河酸和体.
主要成果:
- 物理障碍和生理过程阻碍了有效的药物输送到肝癌细胞.
- 多药耐药性和快速药物清除降低了传统癌症治疗的有效性.
- 向配体显示出改善瘤部位药物递送和度的潜力.
结论:
- 开发向药物分子对于克服HCC目前的治疗局限性至关重要.
- 干介导向提供了一种有希望的方法来增强药物管理和肝癌的特异性.
- 对新的向策略的进一步研究对于推进肝细胞癌治疗至关重要.
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:26Targets for Drug Action: Overview
6.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.4K